Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: rizatriptan benzoate

« Back to Dashboard

Rizatriptan benzoate is the generic ingredient in three branded drugs marketed by Merck, Apotex Inc, Aurobindo Pharma Ltd, Glenmark Generics, Macleods Pharms Ltd, Mylan Pharms Inc, Natco Pharma Ltd, Sandoz, Cipla Ltd, Emcure Pharms Ltd, Invagen Pharms, Sun Pharma Global, and Teva Pharms, and is included in twenty-one NDAs. There is one patent protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for rizatriptan benzoate. Six suppliers are listed for this compound.

Summary for Generic Name: rizatriptan benzoate

Tradenames:3
Patents:1
Applicants:13
NDAs:21
Drug Master File Entries: see list22
Suppliers: see list6
Therapeutic Class:Antimigraine Agents

Pharmacology for Ingredient: rizatriptan benzoate

Clinical Trials for: rizatriptan benzoate

Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1)
Status: Completed Condition: Migraine Disorders

Study of Rizatriptan in the Treatment of Acute Attacks of Post-traumatic Headache in U.S. Military Troops
Status: Recruiting Condition: Chronic Post-traumatic Headache

Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)
Status: Completed Condition: Migraine Headache

Long-Term Exposure to Rizatriptan 5-mg and 10-mg Oral Tablet (Combined Extension Protocols MK-0462-022, MK-0462-025, MK-0462-029)
Status: Completed Condition: Migraine Disorders

A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7)
Status: Completed Condition: Migraine, Acute

Two Rizatriptan Prescribing Portions for Treatment of Migraine
Status: Completed Condition: Migraine

A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)
Status: Completed Condition: Acute Migraine With or Without Aura in Adolescents

A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis
Status: Completed Condition: Migraine

Rizatriptan in Acute Treatment of Migraine in Patients With Unilateral Trigeminal-autonomic Symptoms.
Status: Completed Condition: Migraine

MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029)
Status: Completed Condition: Migraine Headache

Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache
Status: Completed Condition: Migraine With Aura; Migraine Without Aura

Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines?
Status: Completed Condition: Migraine

Treatment of Multiple Attacks of Acute Migraine (0462-025)
Status: Completed Condition: Migraine Headache

Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)
Status: Completed Condition: Migraine

MK0462 in Treatment of Migraine With Recurrence (MK0462-022)
Status: Completed Condition: Migraine Headache

Rizatriptan 10 MG RPD in the Treatment of Acute Migraine
Status: Completed Condition: Migraine

The Effects of Expectation and Knowledge on Rizatriptan and Placebo Treatment of Acute Migraine Headache
Status: Completed Condition: Episodic Migraine

A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)
Status: Completed Condition: Acute Migraine

A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine
Status: Completed Condition: Migraine

A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004)
Status: Completed Condition: Migraine

Study to Test a Marketed Product in the Treatment of Migraine-associated Nausea
Status: Completed Condition: Migraine

Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy
Status: Completed Condition: Migraine

Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)
Status: Completed Condition: Migraine

Telcagepant (MK-0974) Long-Term Safety Study in Adult Participants With Acute Migraine (MK-0974-012)
Status: Completed Condition: Migraine

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)
Status: Completed Condition: Migraine

Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)
Status: Completed Condition: Migraine

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071)
Status: Completed Condition: Migraine

Drug and Non-Drug Treatment Of Severe Migraine
Status: Completed Condition: Migraine Headache

Non-steroidal Anti-inflammatory Drugs Alone or With a Triptan and Reports of Transition From Episodic to Chronic Migraine
Status: Completed Condition: Migraine Disorders

Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy
Status: Completed Condition: Migraine Disorders

A Combination Product of Sumatriptan and Naproxen Sodium Versus Single-entity Oral Triptans: An Analysis of Real World Data
Status: Completed Condition: Migraine Disorders

Treximet ™ Pharmacy Budget Impact Model Database Validation Study
Status: Completed Condition: Migraine Disorders

Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?
Status: Recruiting Condition: Workplace Migraine Treatment

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Invagen Pharms
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET;ORAL204339Jul 1, 2013RXNo<disabled><disabled>
Merck
MAXALT
rizatriptan benzoate
TABLET;ORAL020864Jun 29, 1998RXNo<disabled><disabled>
Cipla Ltd
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET;ORAL077526Mar 26, 2013RXNo<disabled><disabled>
Natco Pharma Ltd
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET;ORAL200482Dec 31, 2012RXNo<disabled><disabled>
Sun Pharma Global
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET;ORAL202047Dec 31, 2012RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc